Clindamycin as an Antimalarial Drug: Review of Clinical Trials
AUTOR(ES)
Lell, Bertrand
FONTE
American Society for Microbiology
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=127356Documentos Relacionados
- Strontium ranelate as a possible disease-modifying osteoarthritis drug: a systematic review
- Poison as cure: a clinical review of botulinum toxin as an invaluable drug
- In Vitro and In Vivo Synergy of Fosmidomycin, a Novel Antimalarial Drug, with Clindamycin
- Potentiation of an antimalarial oxidant drug.
- New approaches in antimalarial drug discovery and development: a review